Mycobacterium bovis BCG and Mycobacterium tuberculosis possess a single arylamine N-acetyltransferase whose gene is predicted to occur within a six-gene operon. Deletion of the nat gene caused an extended lag phase in M. bovis BCG and a cell morphology associated with an altered pattern of cell wall mycolates. Analysis of cDNA from M. bovis BCG shows that during in vitro growth all the genes in the putative nat operon are expressed and the open reading frames are contiguous, supporting the existence of an operon. Two genes in the operon, Mb3599c and Mb3600c, are predicted to encode homologues of enzymes annotated as a 2,3-dihydroxybiphenyl 1,2-dioxygenase (bphC5) and a 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase (bphD2), respectivel...
Arylamine N-acetyltransferase (NAT) acetylates the front-line anti-tuberculosis drug isoniazid (INH)...
Treatment of latent tuberculosis infection remains an important goal of global TB eradication. To th...
New anti-tubercular drugs and drug targets are urgently needed to reduce the time for treatment and ...
Mycobacterium bovis BCG and Mycobacterium tuberculosis possess a single arylamine N-acetyltransferas...
Mycobacterium bovis BCG and Mycobacterium tuberculosis possess a single arylamine N-acetyltransferas...
Mycobacterium bovis BCG and Mycobacterium tuberculosis possess a single arylamine N‐acetyltransferas...
An N-acetyltransferase (NAT) enzyme has been identified in many mycobacterial species. It has been s...
Polymorphic Human arylamine N-acetyltransferase (NAT2) inactivates the anti-tubercular drug isoniazi...
Mycobacterium tuberculosis, the most successful bacterial pathogen, causes tuberculosis, a disease t...
Arylamine N-acetyltransferase (NAT) was first identified in humans for its role in metabolising the ...
Abstract: Polymorphic Human arylamine N-acetyltransferase (NAT2) inactivates the anti-tubercular dru...
Mycolic acids represent a major component of the unique cell wall of mycobacteria. Mycolic acid bios...
Arylamine N-acetyltransferases (NATs, E.C. 2.1.3.5) are enzymes which are found in both eukaryotic a...
International audienceMycobacterium abscessus is the most pathogenic rapid-growing mycobacterium and...
New anti-tubercular drugs and drug targets are urgently needed to reduce the time for treatment and ...
Arylamine N-acetyltransferase (NAT) acetylates the front-line anti-tuberculosis drug isoniazid (INH)...
Treatment of latent tuberculosis infection remains an important goal of global TB eradication. To th...
New anti-tubercular drugs and drug targets are urgently needed to reduce the time for treatment and ...
Mycobacterium bovis BCG and Mycobacterium tuberculosis possess a single arylamine N-acetyltransferas...
Mycobacterium bovis BCG and Mycobacterium tuberculosis possess a single arylamine N-acetyltransferas...
Mycobacterium bovis BCG and Mycobacterium tuberculosis possess a single arylamine N‐acetyltransferas...
An N-acetyltransferase (NAT) enzyme has been identified in many mycobacterial species. It has been s...
Polymorphic Human arylamine N-acetyltransferase (NAT2) inactivates the anti-tubercular drug isoniazi...
Mycobacterium tuberculosis, the most successful bacterial pathogen, causes tuberculosis, a disease t...
Arylamine N-acetyltransferase (NAT) was first identified in humans for its role in metabolising the ...
Abstract: Polymorphic Human arylamine N-acetyltransferase (NAT2) inactivates the anti-tubercular dru...
Mycolic acids represent a major component of the unique cell wall of mycobacteria. Mycolic acid bios...
Arylamine N-acetyltransferases (NATs, E.C. 2.1.3.5) are enzymes which are found in both eukaryotic a...
International audienceMycobacterium abscessus is the most pathogenic rapid-growing mycobacterium and...
New anti-tubercular drugs and drug targets are urgently needed to reduce the time for treatment and ...
Arylamine N-acetyltransferase (NAT) acetylates the front-line anti-tuberculosis drug isoniazid (INH)...
Treatment of latent tuberculosis infection remains an important goal of global TB eradication. To th...
New anti-tubercular drugs and drug targets are urgently needed to reduce the time for treatment and ...